Immune Checkpoint Inhibitors for Hepatobiliary Cancers

Review an on-demand Webcast from a live Webinar focused on current best practices and emerging strategies in using immune checkpoint inhibitors to treat patients with hepatocellular carcinoma and biliary tract cancers and then download the slides and read an associated expert commentary.

Share

Program Content

Activities

ICIs for Hepatobiliary
Immune Checkpoint Inhibitors for Hepatobiliary Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 27, 2021

Expires: January 26, 2022

<i>EP</i>: ICIs for Hepatobiliary
ExpressPoints: Immune Checkpoint Inhibitors for Hepatobiliary Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 28, 2021

Expires: January 27, 2022

Activities

HCC Immuno FAQ
Expert Answers to Clinician Questions on Immune Checkpoint Inhibitors for HCC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 11, 2021

Expires: February 10, 2022

No activities added yet

Faculty

cover img faculity

Amit G. Singal, MD, MS

Chief of Hepatology
Medical Director
, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca